Harvard scientists identified 74 proteins associated with tumor blood Pancreatic cancer is one of the patients with worse prognosis, despite the thousands research teams engaged in the world to try to find an effective treatment. While much of the scientific community turns to determine which genes are involved, to develop effective drugs, Ronald DePinho (New York, 1955), Cancer Institute researcher Dana-Farber and a professor of medicine at Harvard University, says that for now, the way forward faster to cure this type of tumor is to achieve early diagnosis, for which it has developed a specific test that will detect when it can still be curable.
"Having a blood test to detect in the doctor's office the presence of the tumor before symptoms is what is going to have greater impact in the fight against cancer in the coming years, "DePinho said in an interview with the country in Bilbao, where he recently participated in a European congress on molecular genetics .
0 comments:
Post a Comment